IP Library Granted Patent US 10,272,242
Granted Patent B2
US 10,272,242 · App. 15/443,983 · Granted Apr 30, 2019

Device and implantation system for electrical stimulation of biological systems

Inventors: Virender K. Sharma (Paradise Valley, AZ); Edy Sofer (Los Angeles, CA); Paul V. Goode (Round Rock, TX); Bevil Hogg (Murrieta, CA); Shai Policker (Tenafly, NJ); Matthew Joseph Gani (Seattle, WA); Jay Miazga (Seattle, WA); Kaila Raby (Albuquerque, NM)
Assignee: EndoStim, Inc.
A61N1/36007A61B5/4836A61N1/0517A61N1/3606A61N1/3614A61N1/36139A61N1/36171A61N1/36175A61N1/36178A61B5/0538A61B5/1116
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,272,242
App. No.
15/443,983
Granted
Apr 30, 2019
Kind
B2
Abstract

The present specification discloses devices and methodologies for the treatment of GERD. Individuals with GERD may be treated by implanting a stimulation device within the patient's lower esophageal sphincter and applying electrical stimulation to the patient's lower esophageal sphincter, in accordance with certain predefined protocols. The presently disclosed devices have a simplified design because they do not require sensing systems capable of sensing when a person is engaged in a wet swallow, have improved energy storage requirements, enable improved LES function while concurrently delivering additional health benefits, and enable improved LES function post stimulation termination.

Claims (20)

1. A method for treating a patient with gastroesophageal reflux disease, comprising:

programming a stimulator, wherein the stimulator is operably coupled to at least one electrode and wherein the at least one electrode is in electrical communication with the lower esophageal sphincter of the patient, wherein said programming further comprises setting a first pulse amplitude in a range of 3 mA to 8 mA;

applying a plurality of stimulations to the patient, wherein the plurality of stimulations is defined by the first pulse amplitude;

assessing a state of the patient to determine if adverse symptoms associated with the patient's gastroesophageal reflux disease are minimized or if the patient experiences dysphagia; and

depending upon the assessing of the state of the patient, reprogramming the stimulator, wherein the reprogramming further comprises setting a second pulse amplitude in a range of 3 mA to 8 mA and wherein the first pulse amplitude is different from the second pulse amplitude.

2. The method of claim 1 wherein programming the stimulator further comprises setting a first number of stimulations per day in a range of 3 to 24 and wherein the plurality of stimulations is further defined by the first number of stimulations per day.

3. The method of claim 2 wherein reprogramming the stimulator further comprises setting a second number of stimulations per day in a range of 3 to 24 and wherein the first number of stimulations per day is different from the second number of stimulations per day.

4. The method of claim 1 wherein programming the stimulator further comprises setting a first stimulation time in a range of 5 to 60 minutes and wherein the plurality of stimulations is further defined by the first stimulation time.

5. The method of claim 4 wherein reprogramming the stimulator further comprises setting a second stimulation time in a range of 5 to 60 minutes and wherein the first stimulation time is different from the second stimulation time.

6. The method of claim 1 wherein the at least one electrode is placed in electrical communication with a fundus of the patient.

7. The method of claim 1 wherein the first pulse amplitude is selected such that a pressure of the lower esophageal sphincter increases, after a stimulation terminates, for a period of time and then decreases.

8. The method of claim 7 wherein the period of time is up to an hour.

9. The method of claim 1 wherein the stimulator and at least one electrode delivers an electrical pulse having both a higher frequency component and a lower frequency component.

10. The method of claim 1 wherein the first pulse amplitude is selected such that swallowing of the patient is not hindered by the application of the plurality of stimulations.

11. The method of claim 1 wherein the plurality of stimulations is not modified based upon data from a sensor indicative of the patient engaging in swallowing.

12. The method of claim 1 wherein the plurality of stimulations is defined by a first stimulation mode and a second stimulation mode.

13. The method of claim 12 wherein the first stimulation mode is a dose mode which provides a pre-programmed stimulation session per time of day.

14. The method of claim 13 wherein the second stimulation mode is a cyclic mode which provides a stimulation session regularly spaced over a given period of time.

15. The method of claim 1 further comprising applying a second plurality of stimulations to the patient, wherein the second plurality of stimulations is defined by the second pulse amplitude, waiting a second period of time, and assessing a second state of the patient.

16. The method of claim 15 further comprising, depending upon the assessing of the second state of the patient, reprogramming the stimulator, wherein the reprogramming further comprises setting at least one of a stimulation time in a range of 5 to 60 minutes, a third pulse amplitude in a range of 3 mA to 8 mA, and a number of stimulations per day in a range of 3 to 24.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 8, 2022
From: ENDOSTIM (ABC), LLC
To: PARAS HOLDINGS, LLC
Reel/Frame 060616/0882 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 23, 2021
From: ENDOSTIM, INC.
To: ENDOSTIM (ABC), LLC
Reel/Frame 056030/0312 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 12, 2017
From: SHARMA, VIRENDER K.; SOFER, EDY, DR.; GOODE, PAUL V.; HOGG, BEVIL; POLICKER, SHAI; GANI, MATTHEW JOSEPH; MIAZGA, JAY; RABY, KAILA
To: ENDOSTIM, INC.
Reel/Frame 042354/0313 →
Continuity (16)
Continuation 14665226 · Mar 23, 2015
Continuation 13463803 · May 3, 2012
Continuation In Part 13419255 · Mar 13, 2012
Continuation 12300614
Continuation In Part 13041063 · Mar 4, 2011
Provisional Application 60801452 · May 18, 2006
Provisional Application 61482145 · May 3, 2011
Provisional Application 61444849 · Feb 21, 2011
Provisional Application 61422967 · Dec 14, 2010
Provisional Application 61414378 · Nov 16, 2010
Provisional Application 61384105 · Sep 17, 2010
Provisional Application 61371146 · Aug 5, 2010
Provisional Application 61328702 · Apr 28, 2010
Provisional Application 61318843 · Mar 30, 2010
Provisional Application 61310755 · Mar 5, 2010
Related Publication 20170296813A1 · Oct 19, 2017